EUVIMEDEUVIMED entdecken
BeobachtungsstudieQuerschnittstudieOpen Access

Differences in the Prevalence of Use and Dosage of Psychotropic Drugs by Smoking Status in Inpatient and Outpatient: An Observational, Analytical, Cross-Sectional Study

Pedro Damian Gargoloff, Martín A Urtasun, Raul Riveros, Iván Omar Moreno Frade, Martín Cañás

Psychopharmacology Bulletin · 2026

DOI: 10.64719/pb.15417 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Psychopharmacology Bulletin, 2026. Verfasst von Pedro Damian Gargoloff und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gargoloff, MD, Psychiatrist, President of the Psychopharmacology Section and member of the Board of the Argentine Psychiatrists Association (APSA), H…. Hauptthemen laut MEDLINE: Smoking, Antipsychotic Agents, Psychotropic Drugs, Mental Disorders. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To estimate the association between tobacco use and the prevalence of psychotropic medication use and prescribed dosage among inpatients and outpatients with severe mental disorders treated at a neuropsychiatric hospital.

Methods

Observational, cross-sectional, analytical study conducted on May 3, 2023. Smoking status and prescribed psychotropic medications were recorded for all hospitalized patients and community-based outpatients. Dosages were reported in mg/day, defined daily doses (DDD), and for antipsychotics as chlorpromazine equivalents (CPZeq). Bivariate and multivariate analyses were performed.

Results

Tobacco use data were collected from 325 out of 425 total patients (71.7% male, mean age [SD]: 51.4 [14.4] years, 56% inpatients, 70.2% with schizophrenia and related psychosis). The prevalence of smoking was 72.3%, with differences by gender (78.1% in males vs. 57.8% in females, p < 0.001), and decreased with age (18–39 years: 86.1%; 40–59 years: 71.7%; ⩾ 60 years: 63.2%; p = 0.01). Mean dosages of antipsychotics, clozapine, and olanzapine measured in CPZeq were higher in smokers than in non-smokers by 35.4%, 37.1%, and 33.3%, respectively. After adjusting for confounding factors, smoking was associated with a 21.8% higher dosage of antipsychotics (95% CI: 0.4%–43.2%; p = 0.046), equivalent to an additional 132.2 mg/day (24.2–240.1; p = 0.017) of clozapine and 5.4 mg/day (1.2–9.6; p = 0.012) of olanzapine. The average dosage of sedatives/hypnotics was 45.5% higher among smokers (13.6%–89.5%; p = 0.008).

Conclusion

A high prevalence of smoking was found among patients with severe mental disorders, associated with higher average dosages of sedatives/ hypnotics and antipsychotics, particularly clozapine and olanzapine. Psychopharmacology Bulletin. 2026;56(1):48–63.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SmokingAntipsychotic AgentsPsychotropic DrugsMental DisordersHumansMaleFemaleCross-Sectional StudiesAdultMiddle AgedInpatientsOutpatientsYoung AdultAdolescentPrevalenceSchizophreniaOlanzapineAged

Stichwörter der Autor:innen

clozapineolanzapinepharmacokineticsschizophreniatobacco smoking

Substanzen

Antipsychotic AgentsPsychotropic DrugsOlanzapine

Autor:innen und Institutionen

  • Gargoloff, MD, Psychiatrist, President of the Psychopharmacology Section and member of the Board of the Argentine Psychiatrists Association (APSA), Hospital "Dr. Alejandro Korn", Melchor Romero, Argentina, ORCID: 0009-0…
  • Urtasun, MD, Specialist in Internal Medicine, Pharmacology Division, Medical Federation Foundation of the Province of Buenos Aires (FEMEBA), La Plata, Argentina, ORCID: 0000-0001-6018-8250.
  • Riveros, MD, Psychiatrist, Hospital "Dr. Alejandro Korn", Melchor Romero, Argentina, ORCID: 0009-0009-9579-3667.
  • Moreno Frade, MD, Psychiatrist, Hospital "Dr. Alejandro Korn", Melchor Romero, Argentina, ORCID: 0009-0002-9404-4938.
  • Cañás, MD, MSc Master in Pharmacoepidemiology, Pharmacology Division, Medical Federation Foundation of the Province of Buenos Aires (FEMEBA), Universidad Nacional Arturo Jauretche (UNAJ), La Plata, Argentina, ORCID: 000…

Zitieren

APA

Gargoloff, P. D., Urtasun, M. A., Riveros, R., Moreno Frade, I. O., & Cañás, M. (2026). Differences in the Prevalence of Use and Dosage of Psychotropic Drugs by Smoking Status in Inpatient and Outpatient: An Observational, Analytical, Cross-Sectional Study. Psychopharmacology Bulletin. https://doi.org/10.64719/pb.15417

Vancouver

Gargoloff PD, Urtasun MA, Riveros R, Moreno Frade IO, Cañás M. Differences in the Prevalence of Use and Dosage of Psychotropic Drugs by Smoking Status in Inpatient and Outpatient: An Observational, Analytical, Cross-Sectional Study. Psychopharmacology Bulletin. 2026. doi:10.64719/pb.15417

BibTeX
@article{Gargoloff2026,
  author = {Gargoloff, Pedro Damian and Urtasun, Martín A and Riveros, Raul and Moreno Frade, Iván Omar and Cañás, Martín},
  title = {Differences in the Prevalence of Use and Dosage of Psychotropic Drugs by Smoking Status in Inpatient and Outpatient: An Observational, Analytical, Cross-Sectional Study},
  journal = {Psychopharmacology Bulletin},
  year = {2026},
  doi = {10.64719/pb.15417}
}
Kostenlos starten →